This document discusses an exoskeleton called ExoAtlet that aims to provide rehabilitation and improved mobility for patients with disabilities. It is controlled by brain and muscle signals to mimic natural walking patterns. ExoAtlet is being developed in Russia and is estimated to cost $50,000, half the price of similar foreign exoskeletons. The developers have already invested $160 million in research and development and are seeking $137 million more to fund production and marketing efforts. They plan to sell ExoAtlet to rehabilitation centers and provide it to disabled individuals with government grants.